Trinity biotech receives non-compliance notice regarding nasdaq global select requirement for minimum market value of publicly held shares and nasdaq minimum bid price requirement

Dublin, march 14, 2025 (globe newswire) -- trinity biotech plc (nasdaq: trib), a commercial-stage biotechnology company focused on human diagnostics and diabetes management solutions, including wearable biosensors, received notice today from the nasdaq stock market llc (“nasdaq”) that the company is not in compliance with nasdaq listing rule 5450(a)(1), requiring that listed securities maintain a minimum bid price of us $1.00 per share, based on the closing bid price of the company's american depositary shares (“adss”) for the last 30 consecutive business days. the company also received notice today that the company no longer meets the requirement in nasdaq listing rule 5450(b) that listed securities maintain a minimum market value of publicly held shares (“mvphs”) of us $15,000,000, based on nasdaq's review of the company's mvphs for the last 30 consecutive business days.
TRIB Ratings Summary
TRIB Quant Ranking